Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flinn

Showing results (741-750 of 1,037) with videos related to

Pageof 104
Sort By:
Journal of Clinical Immunology|March 15, 2022
Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency-Improved Outcomes in the Modern EraElisabetta Ghimenton, Aisling Flinn, Su Han Lum, et al.
Blood|May 3, 2002
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international studyMichael J Keating, Ian Flinn, Vinay Jain, et al.
Journal of Cell Science|September 15, 2007
Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cellsMirvat El-Sibai, Peri Nalbant, Huan Pang, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2015
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphomaJohn M Burke, Richard H C van der Jagt, Ian W Flinn, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Telomerase mRNA-Lipid nanoparticles attenuate neuroinflammation after traumatic brain injury in miceGoknur Kara, Morgan Holcomb, Anjana Tiwari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvementYvette L Kasamon, Richard J Jones, Steven Piantadosi, et al.
Cancer|March 24, 2007
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetanThomas E Witzig, Arturo Molina, Leo I Gordon, et al.
Blood|October 11, 2014
A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLLJennifer A Woyach, Farrukh Awan, Ian W Flinn, et al.
Scientific Reports|May 23, 2024
Fluorescence shadow imaging of Hypsibius exemplaris reveals morphological differences between sucrose- and CaCl<sub>2</sub>-induced osmobiotesBrendin B Flinn, Hayden M O'Dell, Kara M Joseph, et al.
Planta Medica|October 6, 2006
Year-and-a-half old, dried Echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccinationDavid S Senchina, Lankun Wu, Gina N Flinn, et al.
Pageof 104

Showing results (741-750 of 1,037) with videos related to

Sort By:
Pageof 104
Journal of Clinical Immunology|March 15, 2022
Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency-Improved Outcomes in the Modern EraElisabetta Ghimenton, Aisling Flinn, Su Han Lum, et al.
Blood|May 3, 2002
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international studyMichael J Keating, Ian Flinn, Vinay Jain, et al.
Journal of Cell Science|September 15, 2007
Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cellsMirvat El-Sibai, Peri Nalbant, Huan Pang, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2015
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphomaJohn M Burke, Richard H C van der Jagt, Ian W Flinn, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Telomerase mRNA-Lipid nanoparticles attenuate neuroinflammation after traumatic brain injury in miceGoknur Kara, Morgan Holcomb, Anjana Tiwari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvementYvette L Kasamon, Richard J Jones, Steven Piantadosi, et al.
Cancer|March 24, 2007
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetanThomas E Witzig, Arturo Molina, Leo I Gordon, et al.
Blood|October 11, 2014
A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLLJennifer A Woyach, Farrukh Awan, Ian W Flinn, et al.
Scientific Reports|May 23, 2024
Fluorescence shadow imaging of Hypsibius exemplaris reveals morphological differences between sucrose- and CaCl<sub>2</sub>-induced osmobiotesBrendin B Flinn, Hayden M O'Dell, Kara M Joseph, et al.
Planta Medica|October 6, 2006
Year-and-a-half old, dried Echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccinationDavid S Senchina, Lankun Wu, Gina N Flinn, et al.
Pageof 104